Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current investigational drugs in psoriasis
Caitriona Ryan, Amanda Abramson, Mahir Patel, et al.
Expert Opinion on Investigational Drugs (2012) Vol. 21, Iss. 4, pp. 473-487
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Th17 cell development: from the cradle to the grave
Luis A. Zúñiga, Renu Jain, Christopher J. Haines, et al.
Immunological Reviews (2013) Vol. 252, Iss. 1, pp. 78-88
Closed Access | Times Cited: 199
Mannan induces ROS-regulated, IL-17A–dependent psoriasis arthritis-like disease in mice
Ia Khmaladze, Tiina Kelkka, Simon Guérard, et al.
Proceedings of the National Academy of Sciences (2014) Vol. 111, Iss. 35
Open Access | Times Cited: 135
Research gaps in psoriasis: Opportunities for future studies
Caitriona Ryan, Neil J. Korman, Joel M. Gelfand, et al.
Journal of the American Academy of Dermatology (2013) Vol. 70, Iss. 1, pp. 146-167
Closed Access | Times Cited: 112
Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders
Anna Balato, Emanuele Scala, Nicola Balato, et al.
Expert Opinion on Biological Therapy (2017), pp. 1-12
Closed Access | Times Cited: 67
Successful Therapy of Visceral Leishmaniasis With Curdlan Involves T-Helper 17 Cytokines
Kuntal Ghosh, Gunjan Sharma, Amrita Saha, et al.
The Journal of Infectious Diseases (2012) Vol. 207, Iss. 6, pp. 1016-1025
Open Access | Times Cited: 67
Promising New Treatments for Psoriasis
Sarah Dubois Declercq, Roxane Pouliot
The Scientific World JOURNAL (2013) Vol. 2013, Iss. 1
Open Access | Times Cited: 60
Genetic, Epigenetic and Pharmacogenetic Aspects of Psoriasis and Psoriatic Arthritis
Darren D. O’Rielly, Proton Rahman
Rheumatic Disease Clinics of North America (2015) Vol. 41, Iss. 4, pp. 623-642
Closed Access | Times Cited: 57
Anti cytokine therapy in chronic inflammatory arthritis
Charlotte Thompson, Ruth Davies, Ernest Choy
Cytokine (2016) Vol. 86, pp. 92-99
Closed Access | Times Cited: 49
Psoriatic Arthritis: An Update
Peter Lloyd, Caitriona Ryan, Alan Menter
Arthritis (2012) Vol. 2012, pp. 1-6
Open Access | Times Cited: 49
Genetics of psoriatic arthritis
Darren D. O’Rielly, Proton Rahman
Best Practice & Research Clinical Rheumatology (2014) Vol. 28, Iss. 5, pp. 673-685
Closed Access | Times Cited: 46
Psoriatic arthritis and nail changes: Exploring the relationship
Matthew K. Sandre, Sherry Rohekar
Seminars in Arthritis and Rheumatism (2014) Vol. 44, Iss. 2, pp. 162-169
Closed Access | Times Cited: 40
Drug Discovery against Psoriasis: Identification of a New Potent FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor, 1-(4-((1H-Pyrazolo[3,4-d]pyrimidin-4-yl)oxy)-3-fluorophenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea, That Showed Potent Activity in a Psoriatic Animal Model
Guo‐Bo Li, Shuang Ma, Lingling Yang, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 18, pp. 8293-8305
Closed Access | Times Cited: 32
Early clinical response as a predictor of subsequent response to ixekizumab treatment: results from a phase II study of patients with moderate-to-severe plaque psoriasis
Baojin Zhu, Emily Edson‐Heredia, Gregory S. Cameron, et al.
British Journal of Dermatology (2013) Vol. 169, Iss. 6, pp. 1337-1341
Closed Access | Times Cited: 35
Novel Treatments with Small Molecules in Psoriatic Arthritis
Renata Baronaite Hansen, Arthur Kavanaugh
Current Rheumatology Reports (2014) Vol. 16, Iss. 9
Closed Access | Times Cited: 31
Biological Products for the Treatment of Psoriasis: Therapeutic Targets, Pharmacodynamics and Disease-Drug-Drug Interaction Implications
Jie Wang, Yow‐Ming Wang, Hae‐Young Ahn
The AAPS Journal (2014) Vol. 16, Iss. 5, pp. 938-947
Open Access | Times Cited: 25
Etiopathogenesis of Psoriasis from Genetic Perspective: An updated Review
Shahram Torkamandi, Haleh Mikaeili, Amirhossein Sahebkar, et al.
Current Genomics (2022) Vol. 23, Iss. 3, pp. 163-174
Open Access | Times Cited: 13
A Review of Ustekinumab in the Treatment of Psoriatic Arthritis
Janet Roberts, Darren D. O’Rielly, Proton Rahman
Immunotherapy (2018) Vol. 10, Iss. 5, pp. 361-372
Closed Access | Times Cited: 21
Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports
Clara De Simone, Francesca Perino, Giacomo Caldarola, et al.
Journal of International Medical Research (2016) Vol. 44, Iss. 1_suppl, pp. 67-71
Open Access | Times Cited: 20
Tumour necrosis factor-α inhibitor use in patients with psoriasis with organ transplantation
Bobbak Mansouri, M. Patel, Alan Menter
British Journal of Dermatology (2013) Vol. 169, Iss. 2, pp. 481-483
Closed Access | Times Cited: 16
Apremilast as a treatment for psoriasis
Brandon Shutty, Cameron West, M Pellerin, et al.
Expert Opinion on Pharmacotherapy (2012) Vol. 13, Iss. 12, pp. 1761-1770
Closed Access | Times Cited: 15
Apremilast for the treatment of psoriatic arthritis
Sowmya Varada, Suzanne J. Tintle, Alice B. Gottlieb
Expert Review of Clinical Pharmacology (2014) Vol. 7, Iss. 3, pp. 239-250
Closed Access | Times Cited: 13
Newer targeted therapies in psoriasis
Sujay Khandpur, Neetu Bhari
Indian Journal of Dermatology Venereology and Leprology (2013) Vol. 79, Iss. 7, pp. 47-47
Open Access | Times Cited: 12
Advances in the Genetics of Spondyloarthritis and Clinical Implications
Darren D. O’Rielly, Proton Rahman
Current Rheumatology Reports (2013) Vol. 15, Iss. 8
Closed Access | Times Cited: 12
Therapy for Spondyloarthritis
Philippe Carron, Liesbet Van Praet, Peggy Jacques, et al.
Rheumatic Disease Clinics of North America (2012) Vol. 38, Iss. 3, pp. 583-600
Open Access | Times Cited: 9
Design, Synthesis and in Vitro Degradation of a Novel Co-Drug for the Treatment of Psoriasis
Wing Man Lau, Charles M. Heard, Alex W. White
Pharmaceutics (2013) Vol. 5, Iss. 2, pp. 232-245
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top